RI
ReposiTrak, Inc. (TRAK)·Q1 2026 Earnings Summary
Executive Summary
- Solid quarter with double-digit topline growth: revenue +10% YoY to $5.97M; diluted EPS $0.09, +13% YoY; operating income +28% YoY to $1.89M . Cash ended at $28.8M with no bank debt; cash from operations was $1.54M .
- Versus S&P Global consensus: EPS in line ($0.09), revenue a slight miss (−0.2%); operating execution still strong, aided by automation and cost discipline (SG&A +6% vs revenue +10%) .
- Mix and model resiliency: ~99% recurring revenue; revenue per employee rose to $356K annualized, underscoring automation leverage .
- Capital returns intact: $0.02 quarterly dividend (third 10% raise), ongoing preferred redemptions ($0.75M in Q1) and buybacks; ~50% of annual cash from operations targeted for shareholder returns .
- Watch items: NOLs largely exhausted; effective tax rate to rise above ~6% going forward—moderating EPS conversion despite operating outperformance .
What Went Well and What Went Wrong
What Went Well
- Operating leverage: Revenue grew ~10% while total operating expense grew ~3%; operating income +28% YoY to $1.89M, driven by scale and automation .
- High-quality revenue and productivity: ~99% recurring revenue and $356K revenue per employee annualized signal durable model efficiency .
- Strategic momentum and network effects: CEO highlighted RTN leadership and automation/AI that fixes ~70% initial data errors in the supply chain, enabling scalable onboarding and cross-sell across compliance and supply chain solutions (“garbage in, garbage out” solved via proprietary automation) .
Selected quotes:
- “We continue to grow revenue, expand our operating margins, net margins, earnings per share, and generate substantial cash.” — CEO
- “We delivered $356,000 of revenue per employee on an annualized basis... due to our lean nature, efficient operations, and our ongoing use and expansion of automation.” — CFO
- “We take data… identify and increasingly actually correct the errors automatically.” — CEO
What Went Wrong
- Taxes rising post‑NOL: With NOLs largely used/expired after 30+ profitable quarters, the effective tax rate will be “higher than 6%” going forward, muting conversion from operating income to GAAP net income .
- Cash conversion timing: Cash from operations $1.54M, down from $1.87M a year ago, largely due to conversion of deferred revenue to booked revenue (timing, not demand) .
- Minor revenue shortfall vs consensus: Revenue of $5.97M slightly under S&P consensus of $5.985M, despite internal execution and 99% recurring revenue base (see Estimates Context) .
Industry/macro note:
- Government shutdown effects viewed as modest caution for the food industry (FDA/SNAP), not a material company impact .
Financial Results
GAAP snapshot (oldest → newest)
Notes: Operating margin (calc.) improved YoY in Q1 (IO/Revenue ~31.7% vs ~27.2% last year) based on cited inputs .
Versus S&P Global consensus (oldest → newest)
- Q1: EPS in line; revenue slight miss.
- Q4: More pronounced revenue miss; EPS in line.
- Q3: EPS beat; modest revenue miss.
Estimates and items marked with * are retrieved from S&P Global.
KPIs and balance sheet indicators (oldest → newest)
Segment disclosure: Not provided in Q1 materials; model is subscription SaaS across traceability, compliance, and supply chain .
Guidance Changes
No formal quarterly revenue/EPS guidance ranges issued.
Earnings Call Themes & Trends
Management Commentary
- Strategy and moat: “We’ve established ReposiTrak and RTN as the dominant player… I think over time those advantages will create an even bigger moat” .
- Data integrity as differentiator: “On average the initial data we receive… has a 70% error rate… Our systems… identify and increasingly actually correct the errors automatically” .
- Operating discipline: “We delivered $356,000 of revenue per employee… due to… ongoing use and expansion of automation” .
- Capital allocation and build vs buy: “If M&A opportunities… don’t make financial sense… then let’s build it, not buy it. We are exceptional at building things.” .
- Tax normalization: “Our NOLs… have largely run out… our tax rate will be higher than 6% going forward” .
Q&A Highlights
- Government shutdown: Industry caution via FDA/SNAP, but no material company impact noted .
- TAM expansion via by‑ingredient: Supplier‑driven “middle‑out” pull substantially expands addressable market; referrals propagate both upstream and downstream .
- Platform modernization cost/impact: No meaningful cash expense increase expected; reallocation of capex and developer resources; goal is higher productivity and embedded AI .
- Capital allocation priorities: Continue 50% cash returns, preferred redemptions (~$750K/qtr), evaluate buybacks opportunistically; one‑time dividend not favored .
- M&A: Screen regularly; must be accretive and align with strategy; bias to build if targets don’t meet criteria .
Estimates Context
- Coverage remains thin (one estimate for revenue and EPS each of the last three quarters), limiting “consensus” robustness. Q1 revenue of $5.971M was a −0.2% miss vs $5.985M, while diluted EPS of $0.09 matched the $0.09 mean; EBITDA exceeded consensus (actual ~$2.14M vs ~$2.09M) (S&P Global).
- Given recurring revenue (~99%) and cost control, estimate paths may hold for EPS despite higher taxes; revenue estimates could reflect continued low‑teens growth and cross‑sell momentum, but the tax rate reset implies modestly lower net income conversion versus past NOL‑supported periods .
Estimates and items above marked with * (and EBITDA comparisons) are retrieved from S&P Global.
Key Takeaways for Investors
- Quality growth continues: Double‑digit revenue growth with expanding operating leverage and ~99% recurring revenue underpins durability .
- Execution offsets small revenue miss: EPS in line despite minor revenue shortfall vs S&P consensus as automation supports margins .
- Tax headwind now in focus: With NOLs largely exhausted, a structurally higher tax rate will moderate EPS conversion; factor into forward models .
- Structural advantages compound: RTN scale, data integrity IP, and embedded AI/automation provide a widening moat and cross‑sell catalysts .
- Balance sheet strength enables optionality: $28.8M cash, no debt; consistent capital returns (dividend raises, preferred redemption, buyback capacity) provide support .
- Medium‑term: Platform modernization (AI at the core) should enhance productivity and scalability with limited cash burden—potential upside to margins over time .
- Near‑term trading framework: Watch datapoints on supplier onboarding velocity, deferred revenue trends, and tax‑rate disclosures; beats can come from opex discipline and cross‑sell uptake, while misses likely stem from macro‑related onboarding timing.
Sources:
- Q1 FY26 press release, financial statements and highlights
- Q1 FY26 earnings call transcript
- Q4 FY25 press release and call excerpts
- Q3 FY25 press release and call excerpts
- Dividend press release
Estimates and items marked with * are retrieved from S&P Global.